Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Anesthesia for Catheter Aortic Valve ImplantATIOn Registry (AVIATOR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Deutsches Herzzentrum Muenchen
Sponsor:
Information provided by (Responsible Party):
N Patrick Mayr, Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier:
NCT01390675
First received: June 27, 2011
Last updated: September 3, 2014
Last verified: September 2014
  Purpose

In modern cardiac surgery and cardiology Transcatheter Aortic Valve Implantation (TAVI) is an emerging procedure for high-risk patients that are assumed to be otherwise inoperable. The investigators want to evaluate the specific intraoperative anesthesiologic characteristics cardiac anesthesiologists have to face during these procedures.


Condition
Heart Failure
Excessive Amount of Blood / Fluid Transfusion
Intraoperative Cardiac Arrest During Cardiac Surgery
Critical Incident
Anesthesia

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Deutsches Herzzentrum Muenchen:

Primary Outcome Measures:
  • Perioperative Care [ Time Frame: perioperative ]

Estimated Enrollment: 5000
Study Start Date: June 2011
Estimated Study Completion Date: May 2018
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients undergoing transcatheter aortic valve implantation (TAVI)

Criteria

Inclusion Criteria:

- Patients undergoing transcatheter aortic valve implantation (TAVI)

Exclusion Criteria:

- Refusal by patient

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01390675

Contacts
Contact: Patrick N Mayr, M.D. +49 89 1218 ext 4611 mayrp@dhm.mhn.de
Contact: Peter Tassani, M.D., Ph.D +49 89 1218 ext 4611 tassani@dhm.mhn.de

Locations
Germany
Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München Recruiting
Munich, Bavaria, Germany, D-80636
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Investigators
Principal Investigator: Patrick N Mayr, M.D. Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Principal Investigator: Peter Tassani, M.D., Ph.D Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Principal Investigator: Klaus Martin, M.D. Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Principal Investigator: Thomas Ried, M.D. Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
  More Information

No publications provided

Responsible Party: N Patrick Mayr, MD, Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier: NCT01390675     History of Changes
Other Study ID Numbers: GE DHM-AN-OR-2011/04, GE DHM-AN-OR-2011/04
Study First Received: June 27, 2011
Last Updated: September 3, 2014
Health Authority: Germany: Ethics comittee,Technische Universität München

Additional relevant MeSH terms:
Heart Arrest
Heart Failure
Cardiovascular Diseases
Heart Diseases

ClinicalTrials.gov processed this record on November 25, 2014